title: A case of fulminant type 1 diabetes mellitus, with a precipitous decrease in pancreatic volume, induced by nivolumab for malignant melanoma: analysis of HLA and CTLA-4 polymorphisms.
authors.affiliation: Department of Dermatology.
authors.forename: Kazushi
authors.initials: K
authors.lastname: Ishikawa
authors.affiliation: Department of Dermatology.
authors.forename: Tomoko
authors.initials: T
authors.lastname: Shono-Saito
authors.affiliation: Department of Dermatology.
authors.forename: Tomoko
authors.initials: T
authors.lastname: Yamate
authors.affiliation: Department of Dermatology.
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Kai
authors.affiliation: Department of Dermatology.
authors.forename: Takashi
authors.initials: T
authors.lastname: Sakai
authors.affiliation: Department of Plastic Surgery.
authors.forename: Fumiaki
authors.initials: F
authors.lastname: Shimizu
authors.affiliation: Department of Radiology Faculty of Medicine, Oita University 1-1 Idaigaoka, Hasama-machi Yufu 879-5593, Japan.
authors.forename: Yasunari
authors.initials: Y
authors.lastname: Yamada
authors.affiliation: Department of Radiology Faculty of Medicine, Oita University 1-1 Idaigaoka, Hasama-machi Yufu 879-5593, Japan.
authors.forename: Hiromu
authors.initials: H
authors.lastname: Mori
authors.affiliation: Department of Endocrinology Metabolism and Diabetes, Kindai University Faculty of Medicine 377-2 Ohno-higashi, Osaka-sayama Osaka 589-8511, Japan.
authors.forename: Shinsuke
authors.initials: S
authors.lastname: Noso
authors.affiliation: Department of Endocrinology Metabolism and Diabetes, Kindai University Faculty of Medicine 377-2 Ohno-higashi, Osaka-sayama Osaka 589-8511, Japan.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Ikegami
authors.affiliation: HLA Foundation Laboratory Kyoto, Japan.
authors.forename: Hiroto
authors.initials: H
authors.lastname: Kojima
authors.affiliation: HLA Foundation Laboratory Kyoto, Japan.
authors.forename: Hidenori
authors.initials: H
authors.lastname: Tanaka
authors.affiliation: Department of Dermatology.
authors.forename: Sakuhei
authors.initials: S
authors.lastname: Fujiwara
authors.affiliation: Department of Dermatology.
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Hatano
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D060908:CTLA-4 Antigen / Q000235:genetics*; D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced* / Q000235:genetics; D005260:Female; D006680:HLA Antigens / Q000235:genetics*; D006801:Humans; D008545:Melanoma / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D000077594:Nivolumab; D009929:Organ Size / Q000235:genetics; D010179:Pancreas / Q000473:pathology*; D011110:Polymorphism, Genetic; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D060908:CTLA-4 Antigen; D006680:HLA Antigens; D000077594:Nivolumab